PTK2 and Patent ductus arteriosus: Pretreatment with the FAK inhibitor PF573228 (10 μM), JNK inhibitor SP600125 (30 μM), or integrin α2β1 inhibitor BTT-3033 (2.5 and 5 μM) effectively abolished the PDA-induced adhesion in all cell lines (Figure 7).